1Wallace J, Paauw OS. Appropriate prescribing and important drug interactions in older adults[J]. Med Clin North Am, 2015, 99(2): 295- 310.
2Muhammad A, Naeti S. Pharmacotherapy of type 2 diabetes mellitus: An update on drug-drug interactions[J]. Drug Saf, 2014, 37(11): 903-919.
3American Diabetes Association. Standards of medical care in diabetes: 2013[J]. Diabetes Care, 2013, 36(Suppll): Sl1-S66.
4Phi eli x E, Szendroedi J, Roden M. The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact[J]. Trends Pharmacol Sci, 2011, 32(10): 607-616.
5Graham GG, Punt J, Arora M, et al. Clinical pharmacokinetics of metformin[J]. Clin Pharmacokinet, 2011, 50(2): 81-98.
6Jayasagar G, Krishna Kumar M, Chandrasekhar K, et al. Effect of cephalexin on the pharmacokinetics of metformin in healthy human volunteers[J]. Drug Metabol Drug Interact, 2002, 19(1): 41-48.
7Marathe PH, Wen Y, Norton J, et al. Effect of altered gastric emptying and gastrointestinal motility on metformin absorption[J]. Br J Clin Pharmacol, 2000, 50(4): 325-332.
9Harrower AD. Comparative tolerability of sulphonylureas in diabetes mellitus[J]. Drug Saf, 2000, 22(4): 313-320.
10Holstein A, Beil W. Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions[J]. Expert Opin Drug Metab Toxicol, 2009, 5(3): 225-241.
